MCM
XENT

Matarin Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Matarin Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-179,539
Closed -$6.72M – 318
2018
Q2 		$6.72M Sell
179,539
-71,073
-28% -$2.79M 0.49% 81
2018
Q1 		$9.85M Buy
250,612
+67,261
+37% +$2.46M 0.74% 48
2017
Q4 		$5.94M Buy
183,351
+161,296
+731% +$4.84M 0.46% 77
2017
Q3 		$687K Buy
22,055
+1,119
+5% +$33.1K 0.06% 219
2017
Q2 		$585K Hold
20,936
– – 0.05% 209
2017
Q1 		$359K Buy
20,936
+9,812
+88% +$137K 0.04% 243
2016
Q4 		$135K Buy
+11,124
New +$144K 0.02% 227

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Matarin Capital Management's XENT Position: Q3 2018 in Review

Matarin Capital Management sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 179,539 shares — an estimated $6.72M sold.

Matarin Capital Management first reported a position in XENT in Q4 2016 and held it in 7 quarters. The position peaked at $9.85M in Q1 2018. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Matarin Capital Management reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Matarin Capital Management sold 179,539 Intersect ENT, Inc shares in Q3 2018, an estimated $6.72M.
  • Matarin Capital Management first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 7 quarters.
  • Matarin Capital Management's Intersect ENT, Inc position peaked at $9.85M in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Matarin Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.